CompletedInterventionalNot ApplicableLast updated Apr 20, 2026

Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue in Healthy Participants

Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue (BIO-AGE) in Healthy Participants

Overview

ClinicalTrials.gov ID: NCT05989035
Lead Sponsor: AdventHealth Translational Research InstituteOTHER
Brief Summary: This study is being done to collect Adipose tissue from young and older individuals and gather data on the effect of methionine aminopeptidase protein (MetAP2) inhibition on that Adipose tissue in the laboratory.
Study Type: Interventional

Status

Study Record Dates

NCT06511297Recruiting

Metabolic Control of Aging and Disease - the MetAGE Deep Phenotyping Cohort

NCT06096532Recruiting

Adipose Tissue Blood Flow in Aging Humans

NCT03309007Completed

A Double-Blind, Placebo-Controlled Trial of Anti-Aging, Pro-Autophagy Effects of Metformin in Adults With Prediabetes

NCT05400733Recruiting

Prandial Metabolic Phenotype in Adults

NCT05653258Recruiting

Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects

NCT01737164Completed

Effect of Age on Glucose and Lipid Metabolism